JOHN E. KAO - 13 Mar 2025 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role: Chief Executive Officer, Director
Signature: /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Issuer symbol: ALHC
Transactions as of: 13 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 17 Mar 2025, 17:59:25 UTC
Previous filing: 13 Mar 2025
Next filing: 19 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALHC	Common Stock	Award	$0	+338,710	+7.2%	$0.000000	5,019,252	13 Mar 2025	Direct	F1
holding	ALHC	Common Stock						2,093,100	13 Mar 2025	See Footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents (i) 274,194 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 64,516 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors.
F2	Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Content

Represents (i) 274,194 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 64,516 fully vested shares of Common Stock granted as a discretionary award to the reporting person by the Board of Directors.

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.